The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 06, 2017
Filed:
Oct. 24, 2013
Applicant:
Fresenius Kabi Oncology Limited, New Delhi, IN;
Inventors:
Dhiraj Khattar, Gurgaon, IN;
Rajesh Khanna, Gurgaon, IN;
Sanjay Motwani, Gurgaon, IN;
Sunny Chopra, Gurgaon, IN;
Minakshi Garg, Gurgaon, IN;
Assignee:
Fresenius Kabi Oncology Limited, New Dehli, IN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/706 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 9/08 (2006.01); A61K 31/7068 (2006.01); A61K 47/10 (2017.01); B65B 3/00 (2006.01); B65B 7/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/7068 (2013.01); A61K 47/10 (2013.01); A61K 47/18 (2013.01); B65B 3/003 (2013.01); B65B 7/161 (2013.01);
Abstract
Described herein are ready to use, non-aqueous pharmaceutical compositions comprising 5-aza-2'-deoxycitidine and at least one aprotic solvent. The pharmaceutical compositions may further comprise at least one protic solvent. Also described are processes for preparing the pharmaceutical compositions and their use for the treatment of patients suffering from myelodysplastic syndromes.